Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study

References

• AndersonFDHaitHA multicenter, randomized study of an extended cycle oral contraceptiveContraception2003682899612954519
   PubMed Web of Science ®Google Scholar
• ArcherDFJensenJTJohnsonJVBorisuteHGrubbGSConstantineGDEvaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study resultsContraception200674643944517157099
   PubMed Web of Science ®Google Scholar
• WiegratzIStahlbergSMantheyTEffects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle useContraception2010811576120004274
   PubMed Web of Science ®Google Scholar
• SeidmanDSYeshayaABerAA prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenoneIsr Med Assoc J201012740040520862819
   PubMed Web of Science ®Google Scholar
• CarusoSMalandrinoCCiceroCCiancioFCariolaMCianciAQuality of sexual life of women on oral contraceptive continued-regimen: pilot studyJ Sex Med201310246046623171201
   PubMed Web of Science ®Google Scholar
• Association of Reproductive Health ProfessionalsWhat You Need to Know: Menstrual Suppression2008 Available from: http://www.arhp.org/uploadDocs/menstruationfactsheet.pdfAccessed June 4, 2014
   Google Scholar
• SulakPJKuehlTJCoffeeAWillisSProspective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimenAm J Obstet Gynecol2006195493594116647684
   PubMed Web of Science ®Google Scholar
• JensenJTGarieSGTrummerDElliesenJBleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter studyContraception201286211011822281416
   PubMed Web of Science ®Google Scholar
• KlippingCDuijkersIFortierMPContraceptive efficacy and tolerability of ethinylestradiol 20 mug/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled studyJ Fam Plann Reprod Health Care2012382738322454003
   PubMed Web of Science ®Google Scholar
• BachmannGSulakPJSampson-LandersCBendaNMarrJEfficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenoneContraception200470319119815325887
   PubMed Web of Science ®Google Scholar
• HernadiLMarrJTrummerDDe LeoVPetragliaFEfficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimenContraception2009801182419501211
   PubMed Web of Science ®Google Scholar
• LeteIDovalJLPérez-CamposESelf-described impact of noncompliance among users of a combined hormonal contraceptive methodContraception200877427628218342651
   PubMed Web of Science ®Google Scholar
• AubenyEBuhlerMColauJCVicautEZadikianMChildsMOral contraception: patterns of non-compliance. The Coraliance StudyEur J Contracept Reprod Health Care20027315516112428935
   PubMed Web of Science ®Google Scholar
• SinghSSedghGHussainRUnintended pregnancy: worldwide levels, trends, and outcomesStud Fam Plann201041424125021465725
   PubMed Web of Science ®Google Scholar
• RosenbergMJWaughMSMeehanTEUse and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuationContraception19955152832887628201
   PubMed Web of Science ®Google Scholar
• Bayer Australia LtdConsumer Medicines Information: YAZ^® Flex2013 Available from: http://www.mydr.com.au/medicines/cmis/yaz-flex-tabletsAccessed June 4, 2014
   Google Scholar
• BelseyEMFarleyTMThe analysis of menstrual bleeding patterns: a reviewContraception19883821291563048871
   PubMed Web of Science ®Google Scholar
• KirschBElliesenJPaolettiAWalzerAWiegratzIUser assessments of an adherence-aiding dispenser for daily tablet intake in women receiving the flexible regimen of ethinylestradiol (EE) 20 μg/drospirenone 3 mgProceedings of the 10th European Society of Gynecology CongressSeptember 18–21, 2013Brussels, Belgium
   Google Scholar
• HouMYHurwitzSKavanaghEFortinJGoldbergABUsing daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trialObstet Gynecol2010116363364020733446
   PubMed Web of Science ®Google Scholar
• CastanoPMBynumJYAndresRLaraMWesthoffCEffect of daily text messages on oral contraceptive continuation: a randomized controlled trialObstet Gynecol20121191142022143257
   PubMed Web of Science ®Google Scholar
• LachowskyMLevy-ToledanoRImproving compliance in oral contraception: ‘the reminder card’Eur J Contracept Reprod Health Care20027421021512648292
   PubMed Web of Science ®Google Scholar
• PotterLOakleyDde Leon-WongECanamarRMeasuring compliance among oral contraceptive usersFam Plann Perspect19962841541588853280
   PubMedGoogle Scholar
• MarrJGerlingerCKunzMA historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 mug/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 mug/drospirenone 3 mg administered in a 24/4 regimenEur J Obstet Gynecol Reprod Biol20121621919522391750
   PubMed Web of Science ®Google Scholar
• SzarewskiAvon StenglinARybowskiSWomen’s attitudes towards monthly bleeding: results of a global population-based surveyEur J Contracept Reprod Health Care201217427028322758651
   PubMed Web of Science ®Google Scholar
• AnttilaLBachmannGHernadiLContraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studiesEur J Obstet Gynecol Reprod Biol2011155218018221277674
   PubMed Web of Science ®Google Scholar
• KlippingCDuijkersIFortierMPMarrJTrummerDElliesenJLong-term tolerability of ethinylestradiol 20 mug/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre studyJ Fam Plann Reprod Health Care2012382849322454004
   PubMed Web of Science ®Google Scholar